in the news
Asialaw: OMM and Jingtian Advise Peijia Medical on its US$302 million IPOSeptember 03, 2020
O’Melveny advised Peijia Medical on its US$302 million IPO on the Hong Kong Stock Exchange, this article reported. Peijia Medical is a transcatheter valve therapy medical device and neuro-interventional medical device company based in China.
Asialaw subscribers can read the full article here.